Tiago Lopes: Can AI Predict Immune Reactions of New Drugs?
Tiago Lopes, Research Scientist at Heidelberg University, shared on LinkedIn:
”Can AI predict immune reactions of new drugs? Yes.
Its not perfect, but it is very good.
In this paper fresh from the oven, my colleagues from Japan and I present a new coagulation factor 8 (FVIII), designed and tested as a gene therapy.
People who have a defect in this gene live with hemophilia, a coagulation problem that requires constant injections; and even then, they are at constant risk of joint, muscle and other hemorrhages.
The treatment is super expensive, and still has a major problem of triggering an immune reaction; it renders the treatment ineffective, which without a doubt, sucks.
Here, a comprehensive and reliable AI prediction was made, showing this FVIII variant is not worse than the “original” protein that people have.
Hope. This is the word for patients and their families.
We are working around the clock to have your kids playing soccer without worrying about not walking the next day.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis
-
Aug 15, 2026, 16:58Andrew Jackson: Oral Anticoagulants for the Prophylaxis of Catheter-Related Thrombosis
-
Aug 15, 2026, 16:52Understanding Blood Clots During Pregnancy and After Birth – Thrombosis UK
-
Aug 15, 2026, 16:39Liri Seraj: How Summer Dehydration Affects Blood and Thrombosis Risk
-
Aug 15, 2026, 16:29Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
-
Aug 15, 2026, 16:20Anoop Singh: When India Became the Key to a Faster Hemophilia A Trial